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Abstract
A natural TB infection model using guinea pigs may provide useful information for investigating
differences in transmission efficiency and establishment of active disease by clinical TB strains in
a highly susceptible host under controlled environmental conditions. We sought to examine the
capacity of naturally transmitted multidrug-resistant M. tuberculosis to establish infection and
produce active disease in guinea pigs. Guinea pigs were continuously exposed for 4 months to the
exhaust air of a 6-bed multidrug-resistant tuberculosis inpatient hospital ward in South Africa.
Serial tuberculin skin test reactions were measured to determine infection. All animals were
subsequently evaluated for histologic disease progression at necropsy. Although 75% of the 362
exposed guinea pigs had positive skin test reactions [≥6mm], only 12% had histopathologic
evidence of active disease. Reversions (≥ 6 mm change) in skin test reactivity were seen in 22% of
animals, exclusively among those with reactions of 6 to 13 mm. Only two of 86 guinea pigs with
reversion had histological evidence of disease compared to 47% (31/66) of guinea pigs with large,
non-reverting reactions. Immunosuppression of half the guinea pigs across all skin test categories
did not significantly accelerate disease progression. In guinea pigs that reverted a skin test, a
second positive reaction in 27 (33%) of them strongly suggested re-infection due to ongoing
exposure. These results show that a large majority of guinea pigs naturally exposed to human-
source strains of multidrug-resistant tuberculosis became infected, but that many resolved their
infection and a large majority failed to progress to detectable disease.
Corresponding Author: Ashwin S. Dharmadhikari, adharmadhikari@partners.org, Phone: 617-432-6949, Fax: 617-432-4310.
Request for Reprints: Ashwin S. Dharmadhikari, FXB Building, 7th Floor, 651 Huntington Avenue, Boston, MA 02115
NIH Public Access
Author Manuscript
Tuberculosis (Edinb). Author manuscript; available in PMC 2012 July 01.
Published in final edited form as:














MDR/XDR tuberculosis; guinea pig model; natural infection; skin test reactivity
INTRODUCTION
The propagation of multidrug-resistant (MDR) and extensively drug-resistant (XDR)
tuberculosis (TB) threatens the success of global TB control and rapidly expanding
antiretroviral treatment programs. In the widely publicized outbreak of XDR-TB in
KwaZulu-Natal, South Africa, 55% of the patients had not been previously treated for TB,
but two-thirds had been recently hospitalized and potentially exposed 1. Moreover, 85% of
the XDR patients with genotyped isolates had similar strains, suggesting extensive
transmission in hospitals, other congregate settings, and possibly in the community.
Worldwide, more than 50% of currently reported MDR cases have not been treated
previously, indicating the importance of transmission in propagating the epidemic 2. In
Siberia, Russia, for example, a recent analysis found previous hospitalization for drug
susceptible TB rather than treatment non-adherence as the predominant risk factor (RR>6)
for acquisition of drug-resistant TB, further supporting the contribution of transmission and
re-infection in driving the MDR-TB epidemic 3. In another study in Latvia, molecular
fingerprinting of patient isolates revealed nosocomial transmission to be a highly significant
risk factor for having MDR-TB (OR 18.33) 4. The emerging importance of M/XDR
transmission contrasts sharply with the view promulgated early in the epidemic that drug
resistance mutations conveyed a microbial fitness cost that would greatly limit
propagation 5. A review of the TB fitness literature, however, suggests that drug-resistant
strains exhibit heterogeneous fitness, due in part to compensatory mutations 6. In the context
of such fitness heterogeneity, the capacity of drug-resistant strains to cause disease may be
tied to transmission intensity and opportunity for re-infection as well as host susceptibility 7.
Here we present observations from the natural exposure of guinea pigs to the air from an
experimental hospital ward in which patients infected with MDR/XDR strains of M.
tuberculosis resided. The initial objective in this pilot study was limited to quantifying
human to guinea pig transmission in anticipation of a series of studies to test air disinfection
interventions such as ultraviolet air disinfection, surgical masks on patients, and room air
filtration machines. The study was not designed or funded to characterize human
transmission factors, strain transmissibility or virulence, animal host response, or the impact
of treatment on transmission. However, faced with high rates of tuberculin skin test (TST)
conversions, unexpected skin test reversions, and little evidence of disease progression in
the guinea pigs, we modified the experiment after the initially planned skin testing was
complete by immunosuppressing half the skin test positive guinea pigs with high-dose
corticosteroids in an attempt to promote disease progression and potentially increase the
microbiological yield of isolates from animal tissues to permit matching of guinea pig
isolates with those in patient sputum samples. We also preserved animal tissue samples for
future microbiological and pathological examination.
Guinea pigs have long been used as a surrogate animal model of TB. These animals have
been shown to be uniformly susceptible to M. tuberculosis and to acquire infection after
inhalation of a single droplet nucleus containing no more than a few virulent organisms.
They develop strong delayed type hypersensitivity responses after infection, as detected by
TSTs to purified protein derivative (PPD) 8. When challenged with virulent strains in
laboratory aerosol infection studies, they develop disseminated, multi-organ disease and
eventually succumb to infection after a period of several months 8. The disease that develops
in guinea pigs replicates many important aspects of human TB, including pulmonary and
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extrapulmonary true granulomata with caseous necrosis. In contrast, however, the guinea pig
model is not known to exhibit latency, nor does experimentally induced progressive disease
typically lead to lung cavitation 9–11.
In this study, 75% of the exposed animals developed ≥ 6 mm TST reactions, but only 12%
developed pathologic evidence of active disease despite lengthy follow up. This is an
important observation, because in the laboratory-based low dose aerosol exposure model,
typically, 100% of guinea pigs develop disease, even when challenged with MDR-TB 11, 12.
In the natural exposure model described here, far more akin to TB transmission and
propagation among humans, the majority of guinea pigs did not develop active disease. This
latter model, an updated version of the classic studies by Riley and Wells five decades
ago 13, 14, therefore has the potential to provide new insights into TB transmission and the
complex relationship between naturally transmitted infections and re-infections, delayed-
type hypersensitivity, and the establishment of active disease.
METHODS
Studies were performed at the Airborne Infections Research (AIR) Facility of the Medical
Research Council (in eMahlahleni [formerly known as Witbank], South Africa), a facility
designed to expose susceptible sentinel guinea pigs to airborne tuberculosis (infectious
droplet nuclei) generated by patients with active, culture-proven, mostly sputum smear
positive MDR pulmonary tuberculosis receiving standardized MDR-TB treatment. The AIR
facility is part of the Mpumalanga provincial MDR-TB referral hospital and consists of a 6-
bed inpatient MDR-TB ward connected to 2 guinea pig exposure chambers by an airtight
ventilation system.
HEPA filter treated air enters the patient ward at a rate of 12 air changes per hour and is then
delivered entirely through ventilation ductwork to each of two guinea pig chambers located
in parallel with each other. Within each guinea pig exposure chamber, the air being
delivered from the patient ward emerges from a grid of 60 individual ducts located on a side
wall. Each of these 60 ducts supplies ward air to one cage of animals (1:1 duct to cage ratio).
Each cage holds three animals. The cages are located 1 cm from the opening face of the duct
supplying that cage. Air from the guinea pig chamber is then actively exhausted through a
single exhaust duct located on the ceiling. The direction of air flow ensures that air emerges
from the inlet duct and passes through the guinea pig cages prior to exiting the animal
exposure chamber.
Twenty six patients (11 female, 15 male) with MDR-TB were recruited for this study from
among the patients referred to the adjacent provincial MDR-TB hospital to begin
standardized MDR-TB treatment according to South African guidelines. Informed consent
was obtained for participation in the study. This study was approved by the human studies
committees of the South African MRC, the US CDC, the Harvard School of Public Health,
and the Brigham and Women’s Hospital. Of the 26 patients that had pulmonary MDR-TB
confirmed by culture and first-line drug susceptibility tests performed in various South
African TB reference laboratories, only 13 patients’ isolates were subsequently cultured
from sputum samples obtained after transfer to the AIR facility. Although not an original
aim of this study, these 13 isolates were tested for susceptibility to second line drugs and
genotyped using published methods to allow for potential matching with guinea pig
isolates 15–17.
Patients occupied the AIR Facility in groups of 6 men or 6 women during the 16 week (112
day) exposure phase of the study. These individuals received exactly the same care and
treatment as in the main MDR facility. In order to maximize transmission for this pilot
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study, patients admitted to the main MDR hospital were recruited to the AIR facility study
using the following inclusion criteria: 1) active cough (100%), 2) sputum smear positive for
acid fast bacilli (76%), and 3) cavitary TB by chest radiograph (86%). Fourteen patients
were known to be HIV+, but HIV status was not known in all patients in this pilot study.
Although it takes 2 months on average for sputum to convert to smear negative on the South
African standard MDR-TB regimen 18, patients in the AIR facility were replaced
approximately every 2 weeks (pending suitable alternate subjects) to sample a wider range
of patients. Compared to unselected patients admitted to the main MDR hospital, study
patients were more likely to be female (42 vs. 32%) and to have lung cavitation (86 vs.
59%), but equally likely to be smear positive (both 76%) and culture positive (95 and 96%).
Outbred female, specific pathogen free, Dunkin-Hartley guinea pigs (NHLS, South Africa)
were used in this study. Guinea pigs (n = 362) were acquired at 6 weeks of age weighing
250 – 300 g. Animals were maintained in the AIR Facility animal exposure chambers (3 per
cage) under animal biosafety level 3 conditions at an ambient temperature of 22 ± 1°C,
relative humidity of 50 ± 10% and day/night cycle of 12 hours. Sterile food supplemented
with irradiated hay (NHLS, South Africa) and sterile water supplemented with water-soluble
ascorbic acid (Kyron, South Africa) were provided ad libitum. Animals also underwent
clinical surveillance three times a week and any animals that became ill by explicit criteria
were removed and sacrificed for necropsy. Animal cages had wire mesh floors to reduce the
risk of fecal-oral transmission of infection between animals, a phenomenon known to occur
only late in the course of disseminated disease 19. Animal care was overseen by a licensed
laboratory veterinarian and all protocols were approved by the Animal Use committees of
the South African MRC, the US CDC, and Harvard Medical School.
TST was performed with 100 tuberculin units (2 µg) of commercially produced PPD (Mycos
Research LLC, Loveland, Colorado, USA). In addition to the baseline TST performed prior
to exposure to infectious ward air, animals underwent monthly TSTs during and after MDR-
TB exposure (Figure 1). PPD was diluted immediately before testing and was administered
intradermally on a depilated area of the back. TSTs were read in a blinded, duplicate manner
using digital calipers (Wilson Wolpert, The Netherlands). Two independent readings were
taken at right angles to each other (longitudinal and transverse) at 24 hours post-
administration by a single animal handler, and the results recorded separately in millimeters.
The final diameter of induration was calculated as the average from these four readings. All
reactions were monitored for necrosis. Based on preliminary studies, an induration diameter
of ≥ 6 mm was considered indicative of infection 13, 20. Animals with TST 2 reactions less
than 10 mm were re-tested at months 3 and 4. We defined TST reversion as a decrease in the
TST diameter by at least 6 mm to a final diameter of less than 6 mm. For example, an 11
mm reaction which upon retesting was 5 mm or less would be considered a reversion.
Based on historical and contemporary data from similar experiments using a comparable
antigen dose, TST results were categorized into three groups: non-reactions (0 – 5 mm)
unlikely to represent infection, small reactions (6 – 13 mm) likely to represent limited
infection, or large reactions (≥ 14 mm) likely to represent progressive infection 13, 20. Serial
TSTs for each animal were also categorized by the pattern of reaction through the course of
the study: persistent non-reactions, persistent small reactions, small reactions with reversion,
small reactions with reversion followed by a second positive reaction, and persistent large
reactions.
Guinea pigs were exposed to ward air for 16 weeks. Given the large numbers of animals
being tested, animals were divided into three cohorts separated by a week at each time point.
TST measurements 2, 3, and 4 occurred between weeks 4 – 6, weeks 8 – 10, and weeks 12 –
14 of exposure, respectively (Figure 1). For an individual guinea pig, TST measurements 2
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through 4 occurred exactly 4 weeks apart. A fifth TST was performed between weeks 18 –
20 (after exposure to ward air had ended).
At week 30, guinea pigs that had exhibited a ≥ 6 mm TST reaction at any time point were
randomized to an immunosuppression or saline sham protocol, which consisted of either
0.265 mg Dexa-0.2-phenix/0.1 ml inoculum (equivalent to a dose of 100 mg/kg
hydrocortisone) or saline sham injections subcutaneously 7 days/week on weeks 30, 32, and
34. All skin testing was completed 10 weeks prior to administration of steroids (Figure 1). A
further 4 weeks were allowed for disease progression before the animals were euthanized
and their organs harvested in a systematic fashion.
Guinea pigs were euthanized by intraperitoneal injection of 200 mg/kg sodium pentobarbital
(Euthapent, Kyron Laboratories, SA). Lungs and spleen from all guinea pigs were
aseptically removed. A small portion of tissue was reserved and the remainder was fixed in
formalin. In addition, animals with grossly enlarged hilar lymph nodes or with liver lesions
had samples of these tissues removed for fixation. Formalin preserved portions of organs
were trimmed and processed for paraffin embedding. These paraffin embedded tissues were
cut into 4 µm sections and stained with hematoxylin and eosin. A histopathological grading
system modified and adapted from an acute exposure model was used to evaluate the extent
of tuberculosis lesions in lungs, spleen, lymph nodes, and liver 21, 22. Using this method,
lungs were scored for the presence and severity of seven features/lesions of TB as follows:
(i) estimation of the percent of lung affected ranked at low magnification: 0 – no lesions in
lung, 1 – up to 25% of lung involved, 2 – up to 50% of lung involved, 3 – up to 75% of lung
involved, 4 – above 75% of lung involved. (ii) number of primary lesions: 0 – no primary
lesions present, 1 – a single primary lesion present, 2 – two or more primary lesions present,
multifocal, 3 – two or more primary lesions present, multifocal to coalescing, 4 – multiple
primary lesions, coalescing and extensive. (iii) extent of secondary lesions: 0 – no secondary
lesions present, 1 – up to 25% of lung involved, 2 – up to 50% of lung involved, 3 – up to
75% of lung involved, 4 – above 75% of lung involved. Necrosis (iv), cavitary lesions (v),
mineralization (vi), and fibrosis (vii) were scored for severity on the following scale: 0 –
none, 1 – minimal, 2 – mild, 3 – moderate, 4 – marked. Lung lesion morphology (viii) was
graded from 1 – 4 based on the proportion of macrophages and lymphocytes present in
granulomatous lesions estimated by light microscopic appearance at high magnification (1
represented lesions consisting of all lymphocytes and 4 represented lesions of all
macrophages). All individual scores for these features were summed for a maximal total
lung disease score of 32. The spleen, perihilar lymph nodes, and liver were scored on five
features and their severity as described above: (i) percent organ involvement, (ii) degree of
necrosis, (iii) fibrosis, (iv) mineralization, (v) lesion type. The maximal total score for each
of these organs was 20. Since not all animals had lymph nodes or liver tissue available for
histologic analysis, we used only the results from combined lung and spleen scores
(maximum possible disease score of 52 per guinea pig) in analyses comparing mean disease
severity, but did use presence of disease in any available organs for analyses on proportions
of diseased animals in various groups.
Mean total disease scores were compared for the following categories: guinea pigs 1) with
large and with small reactions; 2) with and without skin test reversion; 3) with large
reactions with and without immunosuppression; and 4) with large reactions on the last skin
test (TST 5) that converted their TST early (on TST 2 or 3) versus late (TST 4 or 5). Since
total disease scores within some groups of guinea pigs were not normally distributed, the
Wilcoxon Rank Sum Test with continuity correction for non-parametric data was used to
compare group means. Skin reactions were analyzed using the Pearson’s product-moment
correlation analysis for TST size and total disease score in the entire guinea pig cohort, as
well as in two subgroups: large TST reactors that had received steroids and large TST
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reactors that had not received steroids. Statistical analyses were performed using R 2.7.0
(www.r-project.org).
Organs from 11 guinea pigs that were euthanized for routine health surveillance after TST 2
and from 19 guinea pigs that were euthanized due to overt illness during the study were
evaluated histologically for TB by a local pathologist (they did not form part of the set of
animals analyzed by the above referenced grading system for this manuscript) and were
cultured immediately after necropsy on solid (LJ) agar and liquid based mycobacterial
culture (MGIT) using published methods 17. Tissue samples from lung, spleen, and visibly
abnormal liver or lymphatic tissue from the remaining guinea pigs that survived to the end
of the exposure period (n = 332) were snap frozen at − 80° C and preserved. Although not
an original aim of the experiment, solid (LJ) agar and liquid based mycobacterial cultures
(MGIT) and genetic fingerprinting of M. tuberculosis isolates using spacer oligonucleotide
genotyping were attempted on these frozen tissues in order to match patient and guinea pig
isolates 17. For these frozen tissues, cultures were initially performed on organ homogenates
of 34/40 guinea pigs that had histologic evidence of TB and 27/292 guinea pigs with small
and large TST reactions but no demonstrable histologic evidence of TB. Since the culture
yield (liquid and solid media) from these previously frozen tissues was low (even among
histology positive, immunosuppressed animals), attempts at culturing remaining guinea pig
tissues were not pursued. Viable isolates were obtained from 18/30 guinea pigs that were
euthanized during the study and cultured immediately after death.
RESULTS
Tuberculin skin test reactions in exposed guinea pigs
In this study 65.7% (n = 238/362) of the guinea pigs underwent all five TST measurements
(the rest were tested only on the first two time points and the fifth time point due to their
early development of reactions >10mm). No animals reacted to the first (baseline) TST
before exposure, but after 1 month exposure (TST 2) 111/362 (30.6%) guinea pigs exhibited
a TST ≥ 6 mm. For the third through the fifth TSTs the cumulative incidence of TST ≥ 6
mm was 55.5%, 62.4%, and 75.0% respectively (Figure 2). Given the occurrence of
reversions at all time points after TST 2, attrition due to deaths (n = 19) or removal after
TST 2 for routine animal health surveillance (n = 11), the point prevalence of positive tests
was 43.7% for TST 3 (n=126/288), 27.9% for TST 4 (n=72/258), and 57.1% for TST 5
(n=194/340). The distribution of reaction sizes for TST 2 appeared normal, with a peak at 10
mm (Figure 3, panel A), but by TST 5 the distribution appeared bimodal, with one peak at 9
mm and a second peak at 19 mm (Figure 3, Panel B).
Reactions remaining consistently < 6 mm on all TSTs (e.g. negative) were observed in 25%
of animals (n= 89/362,) despite 16 weeks of exposure to the patient ward air (Table 1). Just
over half (n=196/362, 54%) of guinea pigs developed small (6–13 mm) TSTs, and
approximately one fifth (n=77/362, 21%) of guinea pigs developed large (≥ 14 mm) TSTs
(Table 1). TST reversion was observed in 81 (22%) of all guinea pigs (Table 1 and Figure 4)
and nearly all reversions were to 0 mm. In 54 of these, TST reactions remained non-reactive
on subsequent testing, while in the other 27 guinea pigs, reversions were followed by other
positive TST reactions. All TST reversions occurred exclusively in guinea pigs that had
small (6–13 mm) rather than large (≥ 14 mm) reactions (Table 1). Incident TST reactions
were randomly distributed within the exposure chambers.
Histopathology analysis
Of the initial 362 guinea pigs, 332 survived to the end of the 4-month exposure period.
Surviving guinea pigs were generally healthy by clinical surveillance criteria, with few
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exceptions. As mentioned earlier, 11 animals were removed from the exposure chambers for
routine health surveillance after being skin positive on TST 2 and 19 animals died from TB
during the study. The tissues from these 30 guinea pigs were not part of the histology
analyses described in this paper. However, organs from the 19 animals that died during the
study were analyzed separately by a local veterinary pathologist and were determined to
have histologic changes due to TB as well as cultures growing M. tuberculosis.
Of 332 animals, 40 (12%) had pathological evidence of tuberculosis in one or more of their
organs (lung, hilar/mediastinal lymph node, spleen, or liver). Nearly half (n=31/66 or 47%)
of guinea pigs with large TSTs had positive histology. The mean total disease score in these
31 animals was 17.8 (st. dev: 8.9; range 1 – 34). Figure 5 shows the distribution of disease
severity in all 66 guinea pigs with large TSTs. In contrast, only 4/178 guinea pigs (2.2%)
with small TSTs had positive histology. Two of these 4 animals had TST reversion and the
other two had persistently small TSTs. Given the low prevalence of disease among guinea
pigs with small TSTs, comparison of disease severity between TST reverter and TST non-
reverter subgroups was not feasible. Additionally, we found that only 2/88 (2.2%) guinea
pigs that never responded to PPD had positive histology. Both of these animals had 0 mm
TSTs on all tests. The mean total disease score for all guinea pigs within each TST group is
shown in Table 2.
Representative photomicrographs of the range and types of lesions seen in the infected
animals are shown in Figure 6. Panel A shows pulmonary cavitation in a guinea pig that had
developed a 13 mm TST after 1 month exposure and showed a 20 mm TST on TST 5. This
guinea pig did not receive steroids. Only 2 other guinea pigs exhibited cavities in the lungs.
Panel B shows a well organized pulmonary granuloma with central caseous necrosis. This
lesion was found in a guinea pig that first developed a 9 mm skin test reaction 2 months
after the start of exposure (on TST 3), maintained skin test reactivity on all subsequent skin
tests, and had a large final skin test reaction measuring 22 mm by TST 5. Despite a 28 week
interval between initial skin test conversion and necropsy, this guinea pig remained
clinically healthy and had limited progression of TB by histology, with disease confined to
the lungs and a hilar lymph node. Panel C demonstrates evidence of lesion mineralization in
an area occupied by a pulmonary granuloma in a guinea pig with large skin test reactions
(15 and 17 mm) that first developed late in the exposure (TST 4). Like the guinea pig
represented in Panel B, the animal represented in Panel C also had limited disease
progression and no evidence of extrapulmonary dissemination, despite 24 weeks between
TST conversion and necropsy. Panel D represents a guinea pig with evidence of
disseminated disease found in multiple organs (lungs, lymph nodes, spleen, liver), with the
photomicrograph showing multiple granulomata in the spleen at low magnification. This
guinea pig remained skin test non-reactive until the last test (TST 5), at which point it had a
20 mm reaction. It received steroids before it was euthanized.
We further stratified guinea pigs that exhibited large reactions on TST 5 based on whether
they had developed their first positive TST early (by TST 2 or 3) versus late (TST 4 or 5) in
relation to the start of exposure period and compared the pathology scores between these
two groups. As shown in Figure 8, mean disease severity was much lower in guinea pigs
with early TST conversions (5.29 vs. 17.47, p<0.001).
Effect of corticosteroid administration
There was no correlation between the pathological score and the size of TST reactions when
results were analyzed in aggregate for all guinea pigs. Moreover, correlation between TST
reaction size and histologic disease severity in guinea pigs that had received steroids was
very weak (r = 0.37, p = 0.03; Fig.7). Neither total disease scores nor the prevalence of any
specific disease feature differed significantly between guinea pigs that had received steroids
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and those that had not (mean total disease score 18.2 vs. 13.8, respectively, p = 0.176; data
on specific disease features not shown).
Harvesting and genotyping of isolates
Of the 26 human subjects and 275 (75%) guinea pigs infected in the study, only 13 patients’
M. tuberculosis isolates and only 18 guinea pigs’ M. tuberculosis isolates were available for
second-line drug susceptibility testing and genotyping. Among the 13 human subject
isolates, 8 different spoligotype patterns were identified. Only two spoligotypes from human
sources identically matched types recovered from the 18 guinea pigs euthanized for signs of
TB and immediately cultured. Five of 18 guinea pigs harbored both spoligotypes. The
remaining 6 spoligotypes found among the 13 isolates from human subjects were either not
transmitted to the guinea pigs or, if they were transmitted, failed to be isolated from the
frozen guinea pig tissues. Environmental mycobacteria were not cultured from any guinea
pig tissues. The culture yield from the guinea pigs that developed TB and had become ill and
were immediately cultured was high (18/19; 95%), whereas the culture yield from the
guinea pigs with histologic evidence of TB that had remained generally healthy during the
study and whose organs were frozen and later cultured was low (8/34;24%).
DISCUSSION
The results of this study show that in the uniformly highly susceptible guinea pig model of
TB, the large majority of animals exposed over 4 months to air exhausted from an inpatient
ward housing patients with MDR/XDR-TB became skin test positive, indicating infection
with M. tuberculosis. However, only a minority of these animals went on to develop active
disease based on histopathology and/or clinical signs. TST responses were also diverse and
included reversions and recurrence of positive reactions over the four month period of
exposure and were not well correlated with histopathology or clinical signs of disease.
Strong evidence that TST reactions to comparable PPD formulations correlate well with M.
tuberculosis infection in naturally exposed guinea pigs comes from the recent and older
literature, and is further confirmed by the suppression of positive skin test responses in
guinea pigs exposed to ultraviolet irradiated air from inpatient TB wards 20, 23–25. Skin test
reactions after natural exposure require microbial replication in the host and are not caused
by inhalation of non-viable organisms 23. Moreover, in our own and previous studies, repeat
skin testing among control, uninfected guinea pigs does not in itself cause TST reactions.
Our observations on transmission of TB by our patient cohort to the guinea pigs are
consistent with several potential hypotheses regarding natural transmission of M/XDR-TB.
First, these strains were likely to have been sufficiently virulent to induce delayed-type
hypersensitivity in a high proportion of exposed guinea pigs, but limited in their capacity to
establish infections leading to progressive disease. These findings stand in contrast to studies
of guinea pigs exposed to clinical MDR isolates in laboratory aerosol chamber studies, in
which the exposure leads to progressive, disseminated, fatal disease that is typically non-
cavitary 11. Second, when progression from infection to active disease occurred in the
current study, it may have been the result of re-infection and/or the presence of particularly
fit, virulent, or sensitizing strains within the cohort. As noted earlier, a few guinea pigs
developed pulmonary cavities, which is unusual in this animal model. The wide range of
disease severity in the guinea pig cohort, even after accounting for time since TST
conversion, underscores the heterogeneity in virulence of strains passed from patients to
guinea pigs and contradicts the notion that drug-resistant strains uniformly lose
virulence 26, 27. Our data highlight the need to better understand the host, pathogen, and
environmental factors driving MDR-TB propagation in the context of natural transmission.
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Of note, guinea pigs also exhibited diverse TST kinetics despite continuous exposure. As
seen in Figures 3A and 3B, the initial single mode around 10 mm for TST 2 evolved into a
bimodal distribution by TST 5, with some TST reactions resolving and even reverting to
zero mm while other reactions increased to give a second mode at 19 mm. About 21% of the
exposed guinea pigs developed large TST reactions, indicating either sustained expansion of
bacterial burden and/or infection with highly sensitizing strains. Of those animals with ≥ 14
mm TST induration on TST 5, 67% had developed their first positive TST (≥ 6 mm)
reaction on TST 2 or 3, rather than on TST 4 or 5. However, despite earlier TST conversion,
increase in TST induration diameter over time, and longer opportunity for disease
progression from time of initial TST conversion, disease burden was lower in this group
than in guinea pigs that developed their first positive skin test reaction on TST 4 or 5. This
paradoxical observation may be evidence of a transient state of infection in this exposure
model, but is also compatible with the transmission of less virulent strains by patients
occupying the ward early in the study, transmission of strains capable of evoking immunity
without disease progression, or possibly transmission of strains capable of immunizing some
guinea pigs against subsequent disease progression after re-infection, resulting in less
pathology but a durable TST response. Indeed, soon after the introduction of INH, Hobby
demonstrated immunization due to non-progressive infection with an INH-resistant M.
tuberculosis strain in the guinea pig model comparable to that produced by BCG 28.
Histology from guinea pigs infected with MDR strains in the current study showed evidence
of healed lesions, limited progression, and examples of spontaneous cure, and these
observations were more frequent in the guinea pigs whose skin test reactions developed
early and evolved into large sized reactions. Further research is needed to clarify whether
there are any protective correlates to durable TST responses in our model.
Twenty-eight percent of the guinea pigs with 6–13 mm reactions reverted their skin tests and
did not develop a subsequent positive skin test when tested. TST reversion may indicate
contraction of immunity as the initial infection resolved, with no induction of a memory
immune response needed to sustain TST reactivity 29. In Riley’s guinea pig exposure
experiment, 6–13 mm TST reactions without necrosis also correlated poorly with findings
on pathology 13. The older literature also suggests that some drug-resistant strains,
especially catalase-negative INH resistant strains, might be of sufficiently low virulence to
spontaneously cure with healing of early pathological lesions in the guinea pig model 30, 31.
The observation that 28% of guinea pigs with small diameter TST reactions lost skin test
reactivity on subsequent testing provides compelling evidence that at least some of the
MDR/XDR strains transmitted by the patients were of limited virulence and may have led to
only transient infection, and is further corroborated by the failure of these strains to either
establish disease in a uniformly highly susceptible animal model of TB or lead to
progressive disease even when the guinea pigs were immunosuppressed with steroids. As
with TST reactivity, the pathogenic course in each guinea pig likely depended on the
virulence of the initial infecting inoculum and the number and virulence of subsequent re-
infecting organisms. Smith considered re-infection an essential pathogenic pathway under
conditions in which either host populations had acquired immunity from prior exposure to
TB, BCG, environmental mycobacteria, or where infecting strains had lost virulence 32.
In interpreting these findings, it is important to contrast this natural exposure model with the
conventional laboratory guinea pig exposure model. In the conventional model, a precise
aerosol with a uniform isolate is delivered under negative pressure within a Madison or
Henderson chamber, and all animals become evenly infected and develop active disease.
This is important for practical reasons, such as vaccine or drug testing 12, 33–35. In the
alternative “natural” exposure model presented here, only a minority of infected animals
developed active disease, a situation akin to natural infection in humans. It is likely that
natural exposure as reported here has uncovered microbial defects in virulence and
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transmission obscured by conventional laboratory exposure models. If highly and uniformly
susceptible animals like guinea pigs can spontaneously survive and clear infection by some
M. tuberculosis strains, as suggested by our observations, it is also possible that protection
by vaccines candidates might be apparent that are otherwise obscured by laboratory chamber
exposures. In addition, the guinea pigs in this experimental model were infected by
organisms transmitted directly from patients, not by organisms cultured under artificial
conditions. Recent microarray data on M. tuberculosis organisms obtained from fresh
sputum suggest that most are metabolically inactive and fat-laden, possibly an adaptation to
the rigors of airborne transport and implantation in a new host 36. Both infectivity and
virulence might be altered when cultured organisms are used.
The experiments here were based on the classical studies of Riley and his colleagues, who
exposed guinea pigs to human source M. tuberculosis under similar natural exposure
conditions 13, 25, 37, 38. In those studies larger TST sizes correlated well with the extent of
disease, but only among guinea pigs with skin reactions associated with necrosis, probably a
result of the cruder tuberculin reagents used at that time. A more recent study in Peru used a
similar approach to ours, albeit with a substantially different patient mix 20. In that study,
guinea pig exposure to patients lasted over 500 days and higher proportions of TST positive
animals with active disease were noted, perhaps attributable to the virulence of strains
transmitted. However, even in that study, examples of guinea pigs with evidence of infection
but without progression to disease were seen. We sampled tissues from all guinea pigs with
TST reversions to establish a more consistent relationship between reversion, transient
infection, and absence of disease. We also immunosuppressed half the guinea pigs and were
still unable to demonstrate recrudescence of disease, further reinforcing the notion that
infections from some of the MDR/XDR strains were transient or of limited virulence.
We are aware of several important limitations regarding this experimental design. Unlike
controlled chamber experiments, we cannot be sure of the exact time and duration of
infection, the infecting dose, the exact frequency of re-infection, or how exposure varied
over time 39. Moreover, lower rates of TST conversions over successive months could have
been due to less infectious patients, less virulent or sensitizing strains, or a reduction in the
number of fully susceptible guinea pigs from continuous exposure. In addition, our ability to
isolate M. tuberculosis from guinea pigs with histologic evidence for TB was only possible
in those animals whose organ homogenates were cultured at the time of death. The yield was
substantially lower in histology positive guinea pigs whose organs had been frozen,
suggesting loss of viability of the isolates responsible for those cases of TB, even in some
guinea pigs with extensive histopathology.
Despite these limitations, under the exposure conditions described, which we believe closely
resemble natural transmission, we observed that a very high percentage of guinea pigs
developed specific tuberculin hypersensitivity--a rate higher than previously seen in earlier
natural exposure experiments 13. Secondly, animals with 6–13 mm TST reactions were
much more likely to revert, but some then became positive for a second time, suggesting re-
infection. Additional evidence of re-infection was seen in the finding of mixed M.
tuberculosis genotypes among several diseased guinea pigs. Thirdly, in contrast to chamber
studies, the majority of sensitized animals failed to progress to active disease or yield
cultivable organisms, even after high dose corticosteroid immunosuppression. This critical
finding strongly suggests spontaneous sterilization of the infection by host immunity. A state
of latency or low-grade persistent infection in some guinea pigs (not showing reversion) is
also possible, but unlikely given the absence of significantly worse disease in guinea pigs
that received high-dose steroids in this study. These observations not only highlight the
complexity of TST reactivity and disease progression after MDR/XDR TB exposure, but
also demonstrate that repeated exposure and re-infection may be an important factor driving
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the development of active disease. A natural infection model of MDR/XDR TB using a
uniformly highly susceptible host like the guinea pig has great potential to provide new
information on the propagation of TB in endemic settings
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Design and time course of study
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Cumulative proportions of guinea pigs with positive (≥ 6 mm) TST results on each skin test.
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Panel A (top): Histogram showing the distribution of TST induration diameters among
guinea pigs on TST 2. X-axis shows induration diameters and y-axis shows number of
guinea pigs. Vertical dashed line illustrates cut-point for positive TST reaction (≥ 6 mm)
Panel B (bottom): Histogram showing the distribution of TST induration diameters among
guinea pigs on TST 5. X-axis shows induration diameters and y-axis shows number of
guinea pigs. Vertical dashed line illustrates cut-point for positive TST reaction (≥ 6 mm)
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Examples of TST reversion in 2 guinea pigs. X axis shows time in weeks and corresponds to
timing of TST 1 through 5. Y axis shows TST induration size in millimeters.
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Disease Severity Among Guinea Pigs with Large TSTs.
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Panel A (top left): Low magnification view of lung tissue from a guinea pig with cavity
formation (1.3×, H&E). Panel B (top right): Low magnification view of lung tissue from a
guinea pig with limited disease progression (4×, H&E). Panel C (bottom left): Low
magnification view of mineralization within a granuloma from a guinea pig with minimal
disease progression (4×, H&E). Panel D (bottom right): low magnification view of multiple
granulomata seen in splenic section from a guinea pig (4×, H&E).
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Plots of correlation between TST diameter and Disease Score, among GPs with large TSTs.
Panel A (left) shows relationship in GPs that received steroids. Panel B (right) shows
relationship in GPs that did not receive steroids.
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Box plot of Disease Score Among Large Reactors on TST 5 grouped by whether GP first
developed its positive TST early or late in the study. Sample means are significantly
different (p<0.001).
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Table 1
Proportions of different TST sizes and reaction patterns in the MDR-TB exposed guinea pig cohort.





0–5 mm reaction 89/362 25%
6–13 mm reaction 196/362 54%
Among 6–13 mm reactors (n = 196)
Reversion – no further reaction 54/196 28%
Reversion – second reaction 27/196 14%
No – reversion 90/196 46%
Other – no opportunity to revert because first positive reaction occurred on TST 5 25/196 12%
14+ mm reaction 77/362 21%
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Table 2
Mean total disease score in guinea pigs of each major TST category.
Guinea Pig Category n (with evaluable
pathology)
Mean (st. dev) Total Disease Score
Non reaction 88 0.14 (0.91)
Small reaction (persistently positive) 62 0.55 (3.03)
Small reaction (reverted) 51 0.10 (0.70)
Large reaction (overall) 66 8.35 (10.82)
Large reaction (received steroids) 32 9.09 (10.89)
Large reaction (no steroids) 34 7.65 (10.87)
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